Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Sorafenib can cause a unique skin reaction.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

ATP helps prevent skin damage from vandetanib by reducing stress.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Bempikibart may help regrow hair in people with alopecia areata.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Tofacitinib is effective and safe for treating severe alopecia areata.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.